ASXAppendix 4C and Quarterly Activities Report - September 2026
other announcement
IBX
Health Care Equipment & Services
Imagion Biosystems
- Short interest
- 0.01%
- 0.00 pp 30d
- as of 24 Dec 2024
- Reported shorts
- 12K
- Shares on issue
- 201.341M
Imagion Biosystems (IBX) News
Latest articles and price-sensitive announcements with AI sentiment classification.
StockheadStockTake: Imagion clears key hurdle for Phase 2 trial
The approval covers trial protocol, informed consent forms and study materials, and clears a key ethics and regulatory requirement. ... Read More The post StockTake: Imagion clears key hurdle for Phase 2 trial appeared first on Stockhead.
IBX Secures Central Ethics Approval - Key Phase 2 Milestone
other announcement
MagSense Nanoparticle Manufacturing Update
other announcement
KalkineWhy Is Imagion (ASX:IBX) Refreshing Clinical Pathway?
Highlights Imagion Biosystems is in focus after its latest market disclosure clarified current operating priorities. The news is relevant to early stage delivery, funding resilience and commercial progress, with delivery and financial resilience central to the market reading. Independent reporting adds context while the company material remains the primary factual reference. Imagion Biosystems (ASX:IBX) is drawing current ASX attention after its latest clinical update added detail about its o...
Application for quotation of securities - IBX
other announcement
Application for quotation of securities - IBX
other announcement
Change of Director's Interest Notices - RP, BM, NW
director_dealing announcement
Google NewsImagion Biosystems Applies to Quote 108.5 Million Ordinary Shares from June Placement Tranche 2 - Kalkine
Imagion Biosystems Applies to Quote 108.5 Million Ordinary Shares from June Placement Tranche 2 Kalkine
Imagion Biosystems (ASX:IBX) Rises 8.33% as MagSense Phase 2 Path Opens - Kalkine
Imagion Biosystems (ASX:IBX) Rises 8.33% as MagSense Phase 2 Path Opens Kalkine
Appendix 4C and Quarterly Activities Report - June 2026
other announcement
Is Imagion Biosystems Ltd (ASX: IBX) an ASX MedTech Stock to Watch? - Kalkine
Is Imagion Biosystems Ltd (ASX: IBX) an ASX MedTech Stock to Watch? Kalkine
Imagion Extends Collaboration with Siemens Healthineers
other announcement
Why Is Imagion Biosystems Ltd (ASX: IBX) Share Price Under Pressure Today? - Kalkine
Why Is Imagion Biosystems Ltd (ASX: IBX) Share Price Under Pressure Today? Kalkine
Change of Director's Interest Notices - RP, BM, NW
director_dealing announcement
StockTake: Imagion Biosystems secures funding for US cancer imaging trial
Firm commitments received for $3.75m to begin a Phase 1B/2 clinical trial of the MagSense HER2 imaging agent. ... Read More The post StockTake: Imagion Biosystems secures funding for US cancer imaging trial appeared first on Stockhead.
Imagion Biosystems (ASX:IBX) raises A$3.75m at a 24% discount to start dosing - Stocks Down Under
Imagion Biosystems (ASX:IBX) raises A$3.75m at a 24% discount to start dosing Stocks Down Under
IBX Secures Firm Commitments for $3.75m for Clinical Trial
other announcement
Imagion gains FDA clearance for HER2 breast cancer trial
The FDA has issued a Study May Proceed Notice for Imagion Biosystems’ Investigational New Drug application. ... Read More The post Imagion gains FDA clearance for HER2 breast cancer trial appeared first on Stockhead.
Imagion Biosystems Receives IND Clearance from US FDA
other announcement
Change of Director's Interest Notice - Robert Proulx
director_dealing announcement
Appendix 4C and Quarterly Activities Report - March 2026
other announcement
Date of AGM and Closing Date for Director Nominations
other announcement
Appendix 3H Lodged Late - Part Repayment of Convertible Note
other announcement